Clinical Trials

Drug Development Drug Efficacy Vaccine Trials Vaccine Efficacy Vaccine Development Oncology Pharmacology Cancer Research Evidence-Based Medicine Psychedelic Research

3 ARTICLES

last mo.

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

Now under Health Canada review, Gilead is exploring licensing deals to counter its US$28,000 annual cost; global roll-out hinges on affordable generic production.

7 ARTICLES

last mo.

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

3 ARTICLES

2mo ago

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

3 ARTICLES

2mo ago

Texas Allocates $50 Million for Ibogaine Treatment Research

5 ARTICLES

2mo ago

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

7 ARTICLES

2mo ago

New Blood Test Diagnoses Celiac Disease Without Forcing Gluten Intake

11 ARTICLES

2mo ago

Three-Year Exercise Program Cuts Colon Cancer Recurrence and Deaths, Study Shows

3 ARTICLES

2mo ago

Ibudilast Fails in Alcohol Use Disorder Trial, Curbs Drinking Among Women

10 ARTICLES

2mo ago

US Stops Recommending COVID-19 Shots for Healthy Kids and Pregnant Women

10 ARTICLES

2mo ago

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer

3 ARTICLES

2mo ago

Smartphone App ECHAS Shows 100% Sensitivity in Detecting Heart Attacks and Strokes

59 ARTICLES

2mo ago

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups

16 ARTICLES

2mo ago

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

5 ARTICLES

3mo ago

Early HIV Vaccine Trials Achieve Precise Immune Activation in Humans

Particle.news

Clinical Trials

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

Genomic Test Predicts Chemotherapy Resistance in Cancer Patients

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection

Dual-Adjuvant HIV Vaccine Elicits Robust Single-Dose Immunity in Mice

CRISPR Technique Reawakens Dormant Genes to Treat Blood Disorders

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

Texas Allocates $50 Million for Ibogaine Treatment Research

Never miss stories about

Clinical Trials

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

New Blood Test Diagnoses Celiac Disease Without Forcing Gluten Intake

Three-Year Exercise Program Cuts Colon Cancer Recurrence and Deaths, Study Shows

Ibudilast Fails in Alcohol Use Disorder Trial, Curbs Drinking Among Women

US Stops Recommending COVID-19 Shots for Healthy Kids and Pregnant Women

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer

Smartphone App ECHAS Shows 100% Sensitivity in Detecting Heart Attacks and Strokes

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

Early HIV Vaccine Trials Achieve Precise Immune Activation in Humans

Never miss stories about

Clinical Trials